Cargando…

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301

BACKGROUND: The aim of this multicenter, randomized phase II study was to analyze the feasibility and safety of alternate-day S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in patients with completely resected pathological stage I (tumor diameter > 2 cm) non-small cell lung cancer (NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okumura, Norihito, Soh, Junichi, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Nakamura, Hiroshige, Sonobe, Makoto, Fujinaga, Takuji, Kataoka, Kazuhiko, Gemba, Kenichi, Kataoka, Masafumi, Hotta, Katsuyuki, Yoshioka, Hiroshige, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101150/ https://www.ncbi.nlm.nih.gov/pubmed/33957881 http://dx.doi.org/10.1186/s12885-021-08232-6

Ejemplares similares

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701
por: Soh, Junichi, et al.
Publicado: (2016)

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201
por: Yamamoto, Hiromasa, et al.
Publicado: (2023)

Review of Setouchi International Art Festival/Setouchi Triennale 2016
por: Tanaka, Kathryn M.
Publicado: (2016)

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2012)

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
por: Sato, Hiroki, et al.
Publicado: (2018)

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
por: Yamamoto, Hiromasa, et al.
Publicado: (2013)

Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
por: Harada, Daijiro, et al.
Publicado: (2021)

Circum‐Setouchi conference: Transboundary support for residents in small‐scale programs
por: Mizumoto, Junki
Publicado: (2020)

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery
por: Fujiwara, Toshiya, et al.
Publicado: (2023)

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3
por: Kato, Terufumi, et al.
Publicado: (2015)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
por: Katsui, Kuniaki, et al.
Publicado: (2019)

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2014)

Histological transformation from non-small cell to small cell lung carcinoma
por: Haruta(Inoue), Yuki, et al.
Publicado: (2016)

A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement
por: Harada, Daijiro, et al.
Publicado: (2019)

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
por: Torigoe, Hidejiro, et al.
Publicado: (2018)

COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review
por: Asai, Nobuhiro, et al.
Publicado: (2021)

microRNA-1301-mediated inhibition of tumorigenesis
por: FANG, LIN, et al.
Publicado: (2011)

Older Adults Used Fewer Home Care Services during the COVID-19 Pandemic: Findings from a Secondary Analysis of an Urgent Survey in Japan
por: Matsumoto, Hiroshige, et al.
Publicado: (2021)

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis
por: Takahashi, Yuta, et al.
Publicado: (2018)

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2018)

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
por: Ogoshi, Yusuke, et al.
Publicado: (2019)

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy
por: Asai, Nobuhiro, et al.
Publicado: (2022)

YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers
por: Takeda, Tatsuaki, et al.
Publicado: (2020)

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non–Small-Cell Lung Cancer: AF-001JP
por: Tamura, Tomohide, et al.
Publicado: (2017)

La propiedad territorial en México, 1301-1810
por: Rivera Marín de Iturbe, Guadalupe
Publicado: (1983)

Aberrant Expression of miR-1301 in Human Cancer
por: Zhong, Chenming, et al.
Publicado: (2022)

Congenital partial pericardial defect confirmed based on spontaneous pneumothorax: A case report and literature review
por: Date, Naoki, et al.
Publicado: (2020)

Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma after Lung Resection
por: Nishikawa, Shigeto, et al.
Publicado: (2019)

Noninvasive assessment for acute allograft rejection in a rat lung transplantation model
por: Takahashi, Ayuko, et al.
Publicado: (2014)

The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
por: Kugelberg, Elisabeth, et al.
Publicado: (2010)

Sistemas contraincendios a base de gas Halon 1301
por: Méndez Hernández, Julio
Publicado: (1993)

Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells
por: Michlewska, Sylwia, et al.
Publicado: (2020)

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma
por: Namba, Kei, et al.
Publicado: (2019)

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer
por: Sato, Hiroki, et al.
Publicado: (2018)

FP13.01 Assessment of the Fear of COVID-19 and Its Impact on Lung Cancer Screening Participation Among the Korean General Population
por: Duong, L., et al.
Publicado: (2021)

Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol
por: Nishii, Kazuya, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
por: Nakaya, Aya, et al.
Publicado: (2018)

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
por: Hamada, Akira, et al.
Publicado: (2021)

Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer
por: Kaneda, Toshihiko, et al.
Publicado: (2022)

Wireless power transmission for sustainable electronics: cost wipe - IC1301
por: Borges Carvalho, Nuno, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5irc81at3u6qnlk7rvd3rh3d65